Financial conflicts of interest in physicians' relationships with the pharmaceutical industry—self-regulation in the shadow of federal prosecution
DM Studdert, MM Mello… - New England Journal of …, 2004 - Mass Medical Soc
Studdert et al. describe recent efforts by the federal government and professional
organizations to tighten the regulation of financial associations between physicians and the …
organizations to tighten the regulation of financial associations between physicians and the …
Doctors and drug companies—scrutinizing influential relationships
EG Campbell - New England Journal of Medicine, 2007 - Mass Medical Soc
On September 6, Senators Charles Grassley and Herb Kohl introduced the Physician
Payments Sunshine Act. Eric Campbell discusses the implications of the bill, which would …
Payments Sunshine Act. Eric Campbell discusses the implications of the bill, which would …
Trust and transparency: patient perceptions of physicians' financial relationships with pharmaceutical companies
JE Perry, D Cox, AD Cox - Journal of Law, Medicine & Ethics, 2014 - cambridge.org
Financial relationships and business transactions between physicians and the health care
industry are common. These relationships take a variety of forms, including payments to …
industry are common. These relationships take a variety of forms, including payments to …
Limiting the influence of pharmaceutical industry gifts on physicians: self-regulation or government intervention?
D Grande - Journal of general internal medicine, 2010 - Springer
Concerns over the influence of pharmaceutical gifts on physicians have surged in recent
years. This has prompted wide ranging legislative proposals in numerous states and in the …
years. This has prompted wide ranging legislative proposals in numerous states and in the …
Payments to physicians: does the amount of money make a difference?
B Lo, D Grady - Jama, 2017 - jamanetwork.com
ThefederalOpenPaymentsdatabasemakesp… amount and type of payments from drug and
device companies to individual physicians. 1 It seems plausible that very large payments …
device companies to individual physicians. 1 It seems plausible that very large payments …
A ray of sunshine: transparency in physician-industry relationships is not enough
J Lexchin, A Fugh-Berman - Journal of General Internal Medicine, 2021 - Springer
Gifts from pharmaceutical and medical device companies to physicians in the United States
have been reported since 2014, through the Physician Payments Sunshine Act. Although …
have been reported since 2014, through the Physician Payments Sunshine Act. Although …
New developments in managing physician-industry relationships
DJ Rothman, S Chimonas - JAMA, 2008 - jamanetwork.com
OVER THE PAST2YEARS, POLICIES GOVERNING THE RE-lationship between physicians
and pharmaceuti-calanddevicecompanieshaveundergonere… changes. A 2004 task force …
and pharmaceuti-calanddevicecompanieshaveundergonere… changes. A 2004 task force …
Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach
DL Coleman, AE Kazdin, LA Miller, JS Morrow… - Academic …, 2006 - journals.lww.com
A productive and ethical relationship between the pharmaceutical industry and physicians is
critical to improving drug discovery and public health. In response to concerns about …
critical to improving drug discovery and public health. In response to concerns about …
Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution?
TR Insel - JAMA, 2010 - jamanetwork.com
PSYCHIATRISTS HAVE RARELY ENJOYED A SURPLUS OF PUB-lic trust. During the past
3 years, public trust in psy-chiatry has been further undermined with accusations that several …
3 years, public trust in psy-chiatry has been further undermined with accusations that several …
Health industry practices that create conflicts of interest: a policy proposal for academic medical centers
TA Brennan, DJ Rothman, L Blank, D Blumenthal… - Jama, 2006 - jamanetwork.com
Conflicts of interest between physicians' commitment to patient care and the desire of
pharmaceutical companies and their representatives to sell their products pose challenges …
pharmaceutical companies and their representatives to sell their products pose challenges …